![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0347.jpg)
Progression-free and overall survival of early positron emission
tomography (PET)–positive patients
. (A) progression-free and (B)
overall survival of early PET-positive patients who were randomly assigned to
treatment with either standard ABVD + involved-node radiotherapy (INRT; n =
192) or experimental BEACOPPesc + INRT (n = 169).
Published in: Marc P.E. André; et al ;
JCO
2017,
35, 1786-1794
.
Copyright © 2017 American Society of Clinical Oncology
PFS
OS